Legal Representation
Attorney
Douglas R. Wolf
USPTO Deadlines
Next Deadline
1023 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20181023)
Due Date
October 23, 2028
Grace Period Ends
April 23, 2029
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 21, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 21, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 21, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 21, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| May 21, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 6, 2024 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | Loading... |
| Feb 6, 2024 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED | Loading... |
| Feb 6, 2024 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Dec 4, 2023 | ES8R | I | TEAS SECTION 8 RECEIVED | Loading... |
| Oct 23, 2023 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jan 28, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jan 28, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 28, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jan 28, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jan 28, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Dec 2, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Dec 2, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 2, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 2, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 2, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 23, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 20, 2018 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Sep 19, 2018 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Sep 5, 2018 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Aug 6, 2018 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 5, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 6, 2018 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 17, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 3, 2018 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| Feb 21, 2018 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Jan 23, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 23, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 3, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 8, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 5, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 5, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 5, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 7, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 7, 2017 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 7, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 30, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 31, 2017 | MPMK | E | NOTICE OF PSEUDO MARK E-MAILED | Loading... |
| Mar 30, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 044
Genomic and molecular medical testing for cancer and other diagnostic or treatment purposes; diagnostic services, namely, medical diagnostic testing for cancer and other diseases and disorders; providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals
First Use Anywhere:
20171200
First Use in Commerce:
20171200
Additional Information
Pseudo Mark
FOUNDATION ONE CDX
Classification
International Classes
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CDX"